Ashley Gallagher, MA

The filing acceptance marks a step toward lower-cost alternatives to Mounjaro and Zepbound.

Updated charter shifts committee governance to the CDC director and drops fixed meeting schedules.

New analyses from the MAESTRO program and real-world studies bolster the evidence base for the metabolic dysfunction-associated steatohepatitis therapy.

A new sibling-matched cohort study challenges earlier observational data, offering pharmacists evidence-based reassurance to share with pregnant patients.

Coadministering COVID-19 and influenza vaccines did not raise the 90-day risk of serious or clinically meaningful adverse events.

As cases approach the full-year 2025 total, declining vaccination coverage and vaccine hesitancy put pharmacists on the front lines of a public health crisis.

The approval extends risankizumab to children 6 years and older and introduces a new weight-based 55 mg prefilled syringe.

Independent pharmacies turn software into profit through smarter purchasing, real-time benefits, medical billing, and OTC prompts that boost margins and care.

Pharmacists turn summit insights into decisive change, boosting independent pharmacy leadership, clinical care, and readiness for 2026 reform.

Community pharmacists help men overcome care avoidance with walk-in screenings, private consults, and outreach.

Bryan Wheeler, PharmD, discusses how the Medicare GLP-1 Bridge program works and what it means for independent pharmacy operations.

Direct-to-patient drug programs and telehealth reshape pharmacy, and community pharmacists are an essential component.

Pharmacists leverage CGM and automated insulin delivery to personalize diabetes care, prevent errors, and expand equitable access to technology.

AAP challenges HHS as ACIP stalls, leaving pharmacists and health care in limbo on vaccine coverage and respiratory recommendations.

Pharmacies boost profits by embedding clinical service alerts into dispensing workflows and improving documentation.

The first generic rifapentine expands affordable treatment for active and latent tuberculosis.

Retracted vaccine-autism study exposes statistical flaws, reigniting hepatitis B birth-dose debate and highlighting why pharmacists must rely on evidence-based data.

Independent pharmacies boost margins with business insights and smart automation, shifting from dispensing to sustainable growth.

Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.

Independent pharmacies can profit from immunizations, boosting loyalty and OTC sales with smart vaccine purchasing and efficient workflows.

Pharmacists guide safe OTC allergy choices and compare Allegra, Claritin, and Zyrtec for fast, 24-hour relief from sneezing and itchy eyes.

Pharmacists help spot nonresponders, navigate accurate testing, and speed diagnosis.

FDA advisors back Moderna’s mRNA flu shot for older adults, hinting at a potential egg-free option for 2026–2027.

The ACTIV-6 trial suggests early metformin may halve clinician-diagnosed long COVID risk, offering a low-cost option pharmacists can apply safely.

Community pharmacists help prevent chronic wounds with early triage, modern dressing guidance, and diabetic foot care.

FDA clears first generic Xofluza tablet, bringing affordable single-dose flu treatment and prevention.

Community pharmacies redesign workflows to address insurance barriers and deliver safer, gender-affirming care.

A study examining naloxone sales found that retail OTC sales have been surprisingly limited despite improvements in access.

This decision marks a milestone in clinical pharmacy as it targets the underlying autoimmune destruction of pancreatic beta cells.

FDA clears first OTC CGM for children 2 years and older, expanding tracking beyond prescriptions for pediatric populations.